1 Human Organoids Market Overview

• 1.1 Product Overview and Scope of Human Organoids
• 1.2 Human Organoids Segment by Type
  • 1.2.1 Global Human Organoids Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Ready To Use Products
  • 1.2.3 Customizable Products
• 1.3 Human Organoids Segment by Application
  • 1.3.1 Human Organoids Sales Comparison by Application: (2021-2027)
  • 1.3.2 Developmental Biology
  • 1.3.3 Drug Toxicity & Efficacy Testing
  • 1.3.4 Disease Pathology
  • 1.3.5 Personalized Medicine
  • 1.3.6 Regenerative Medicine
  • 1.3.7 Other
• 1.4 Global Human Organoids Market Size Estimates and Forecasts
  • 1.4.1 Global Human Organoids Revenue 2016-2027
  • 1.4.2 Global Human Organoids Sales 2016-2027
  • 1.4.3 Human Organoids Market Size by Region: 2016 Versus 2021 Versus 2027

2 Human Organoids Market Competition by Manufacturers

• 2.1 Global Human Organoids Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Human Organoids Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Human Organoids Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Human Organoids Manufacturing Sites, Area Served, Product Type
• 2.5 Human Organoids Market Competitive Situation and Trends
  • 2.5.1 Human Organoids Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Human Organoids Players Market Share by Revenue
  • 2.5.3 Global Human Organoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Human Organoids Retrospective Market Scenario by Region

• 3.1 Global Human Organoids Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Human Organoids Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Human Organoids Market Facts & Figures by Country
  • 3.3.1 North America Human Organoids Sales by Country
  • 3.3.2 North America Human Organoids Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Human Organoids Market Facts & Figures by Country
  • 3.4.1 Europe Human Organoids Sales by Country
  • 3.4.2 Europe Human Organoids Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Human Organoids Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Human Organoids Sales by Region
  • 3.5.2 Asia Pacific Human Organoids Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Human Organoids Market Facts & Figures by Country
  • 3.6.1 Latin America Human Organoids Sales by Country
  • 3.6.2 Latin America Human Organoids Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Human Organoids Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Human Organoids Sales by Country
  • 3.7.2 Middle East and Africa Human Organoids Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Human Organoids Historic Market Analysis by Type

• 4.1 Global Human Organoids Sales Market Share by Type (2016-2021)
• 4.2 Global Human Organoids Revenue Market Share by Type (2016-2021)
• 4.3 Global Human Organoids Price by Type (2016-2021)

5 Global Human Organoids Historic Market Analysis by Application

• 5.1 Global Human Organoids Sales Market Share by Application (2016-2021)
• 5.2 Global Human Organoids Revenue Market Share by Application (2016-2021)
• 5.3 Global Human Organoids Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 BioIVT (US)
  • 6.1.1 BioIVT (US) Corporation Information
  • 6.1.2 BioIVT (US) Description and Business Overview
  • 6.1.3 BioIVT (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 BioIVT (US) Product Portfolio
  • 6.1.5 BioIVT (US) Recent Developments/Updates
• 6.2 Thermo Fisher Scientific (US)
  • 6.2.1 Thermo Fisher Scientific (US) Corporation Information
  • 6.2.2 Thermo Fisher Scientific (US) Description and Business Overview
  • 6.2.3 Thermo Fisher Scientific (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Thermo Fisher Scientific (US) Product Portfolio
  • 6.2.5 Thermo Fisher Scientific (US) Recent Developments/Updates
• 6.3 ZenBio (US)
  • 6.3.1 ZenBio (US) Corporation Information
  • 6.3.2 ZenBio (US) Description and Business Overview
  • 6.3.3 ZenBio (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 ZenBio (US) Product Portfolio
  • 6.3.5 ZenBio (US) Recent Developments/Updates
• 6.4 Corning (US)
  • 6.4.1 Corning (US) Corporation Information
  • 6.4.2 Corning (US) Description and Business Overview
  • 6.4.3 Corning (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Corning (US) Product Portfolio
  • 6.4.5 Corning (US) Recent Developments/Updates
• 6.5 Organovo (US)
  • 6.5.1 Organovo (US) Corporation Information
  • 6.5.2 Organovo (US) Description and Business Overview
  • 6.5.3 Organovo (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Organovo (US) Product Portfolio
  • 6.5.5 Organovo (US) Recent Developments/Updates
• 6.6 Cyprio (France)
  • 6.6.1 Cyprio (France) Corporation Information
  • 6.6.2 Cyprio (France) Description and Business Overview
  • 6.6.3 Cyprio (France) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Cyprio (France) Product Portfolio
  • 6.6.5 Cyprio (France) Recent Developments/Updates
• 6.7 Biopredic International (France)
  • 6.6.1 Biopredic International (France) Corporation Information
  • 6.6.2 Biopredic International (France) Description and Business Overview
  • 6.6.3 Biopredic International (France) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Biopredic International (France) Product Portfolio
  • 6.7.5 Biopredic International (France) Recent Developments/Updates
• 6.8 CELLINK (Sweden)
  • 6.8.1 CELLINK (Sweden) Corporation Information
  • 6.8.2 CELLINK (Sweden) Description and Business Overview
  • 6.8.3 CELLINK (Sweden) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 CELLINK (Sweden) Product Portfolio
  • 6.8.5 CELLINK (Sweden) Recent Developments/Updates
• 6.9 Emulate (US)
  • 6.9.1 Emulate (US) Corporation Information
  • 6.9.2 Emulate (US) Description and Business Overview
  • 6.9.3 Emulate (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Emulate (US) Product Portfolio
  • 6.9.5 Emulate (US) Recent Developments/Updates
• 6.10 Hrel Corporation (US)
  • 6.10.1 Hrel Corporation (US) Corporation Information
  • 6.10.2 Hrel Corporation (US) Description and Business Overview
  • 6.10.3 Hrel Corporation (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Hrel Corporation (US) Product Portfolio
  • 6.10.5 Hrel Corporation (US) Recent Developments/Updates
• 6.11 InSphero (Switzerland)
  • 6.11.1 InSphero (Switzerland) Corporation Information
  • 6.11.2 InSphero (Switzerland) Human Organoids Description and Business Overview
  • 6.11.3 InSphero (Switzerland) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 InSphero (Switzerland) Product Portfolio
  • 6.11.5 InSphero (Switzerland) Recent Developments/Updates
• 6.12 Kerafast (US)
  • 6.12.1 Kerafast (US) Corporation Information
  • 6.12.2 Kerafast (US) Human Organoids Description and Business Overview
  • 6.12.3 Kerafast (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Kerafast (US) Product Portfolio
  • 6.12.5 Kerafast (US) Recent Developments/Updates
• 6.13 Kirkstall (UK)
  • 6.13.1 Kirkstall (UK) Corporation Information
  • 6.13.2 Kirkstall (UK) Human Organoids Description and Business Overview
  • 6.13.3 Kirkstall (UK) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Kirkstall (UK) Product Portfolio
  • 6.13.5 Kirkstall (UK) Recent Developments/Updates
• 6.14 MIMETAS (Netherlands)
  • 6.14.1 MIMETAS (Netherlands) Corporation Information
  • 6.14.2 MIMETAS (Netherlands) Human Organoids Description and Business Overview
  • 6.14.3 MIMETAS (Netherlands) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 MIMETAS (Netherlands) Product Portfolio
  • 6.14.5 MIMETAS (Netherlands) Recent Developments/Updates
• 6.15 Pandorum Technologies (India)
  • 6.15.1 Pandorum Technologies (India) Corporation Information
  • 6.15.2 Pandorum Technologies (India) Human Organoids Description and Business Overview
  • 6.15.3 Pandorum Technologies (India) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Pandorum Technologies (India) Product Portfolio
  • 6.15.5 Pandorum Technologies (India) Recent Developments/Updates
• 6.16 Promethera Biosciences (Belgium)
  • 6.16.1 Promethera Biosciences (Belgium) Corporation Information
  • 6.16.2 Promethera Biosciences (Belgium) Human Organoids Description and Business Overview
  • 6.16.3 Promethera Biosciences (Belgium) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Promethera Biosciences (Belgium) Product Portfolio
  • 6.16.5 Promethera Biosciences (Belgium) Recent Developments/Updates
• 6.17 Miromatrix (US)
  • 6.17.1 Miromatrix (US) Corporation Information
  • 6.17.2 Miromatrix (US) Human Organoids Description and Business Overview
  • 6.17.3 Miromatrix (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Miromatrix (US) Product Portfolio
  • 6.17.5 Miromatrix (US) Recent Developments/Updates
• 6.18 System1 Biosciences (US)
  • 6.18.1 System1 Biosciences (US) Corporation Information
  • 6.18.2 System1 Biosciences (US) Human Organoids Description and Business Overview
  • 6.18.3 System1 Biosciences (US) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 System1 Biosciences (US) Product Portfolio
  • 6.18.5 System1 Biosciences (US) Recent Developments/Updates
• 6.19 Cyfuse Biomedical (Japan)
  • 6.19.1 Cyfuse Biomedical (Japan) Corporation Information
  • 6.19.2 Cyfuse Biomedical (Japan) Human Organoids Description and Business Overview
  • 6.19.3 Cyfuse Biomedical (Japan) Human Organoids Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Cyfuse Biomedical (Japan) Product Portfolio
  • 6.19.5 Cyfuse Biomedical (Japan) Recent Developments/Updates

7 Human Organoids Manufacturing Cost Analysis

• 7.1 Human Organoids Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Human Organoids
• 7.4 Human Organoids Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Human Organoids Distributors List
• 8.3 Human Organoids Customers

9 Human Organoids Market Dynamics

• 9.1 Human Organoids Industry Trends
• 9.2 Human Organoids Growth Drivers
• 9.3 Human Organoids Market Challenges
• 9.4 Human Organoids Market Restraints

10 Global Market Forecast

• 10.1 Human Organoids Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Human Organoids by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Human Organoids by Type (2022-2027)
• 10.2 Human Organoids Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Human Organoids by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Human Organoids by Application (2022-2027)
• 10.3 Human Organoids Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Human Organoids by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Human Organoids by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Ready To Use Products
Customizable Products

Segment by Application
Developmental Biology
Drug Toxicity & Efficacy Testing
Disease Pathology
Personalized Medicine
Regenerative Medicine
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
BioIVT (US)
Thermo Fisher Scientific (US)
ZenBio (US)
Corning (US)
Organovo (US)
Cyprio (France)
Biopredic International (France)
CELLINK (Sweden)
Emulate (US)
Hrel Corporation (US)
InSphero (Switzerland)
Kerafast (US)
Kirkstall (UK)
MIMETAS (Netherlands)
Pandorum Technologies (India)
Promethera Biosciences (Belgium)
Miromatrix (US)
System1 Biosciences (US)
Cyfuse Biomedical (Japan)